生命科学资讯

Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease

Renal PIEZO2 is an essential regulator of renin

A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis

Chutes & Ladders—Yet another CDER leadership shake-up

Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA

Cancer blood test developer Freenome to go public in $330M SPAC deal

Biopharma sentiment hit a turning point in October

OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio

Hemophilia gene therapies are struggling on the market, even as innovation soars

Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use

Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga

Laigo raises €11.5M seed money for targeted protein degradation

FDA conflicts of interest extend beyond adcomm experts

New FGFR3 inhibitors disclosed in Onco3r Therapeutics patent

Synnovation Therapeutics discovers new NRF2 inhibitors

Holiday notice

Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat

German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme

Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability